HIMSS May 13, 2020
Under the Drug Supply Chain Security Act (DSCSA), the U.S. pharmaceutical supply chain will be brought together by an electronic, interoperable system to identify and trace prescription drugs as they’re distributed throughout the country. This has radical implications for the entire industry, as regulators and stakeholders all race the clock to transform how drugs reach the patients who need them.
In today’s drug supply chain, DSCSA-compliant verification is rare; but once it becomes required, without a real-time system that allows for single scans and near-instant verification, pharmacies will bear a massive regulatory burden.
To address these needs, a peer-reviewed study was commissioned in partnership with UCLA Health to deploy and test a last-mile blockchain-driven solution for caregivers to use in...
Today's Sponsors
Today's Sponsor